Lubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastrointestinal epithelial cells. Activation of these channels promotes the secretion of a chloride-rich fluid that soften the stool, increase gastrointestinal motility, and induce spontaneous bowel movements (SBM). It is grouped under the following drug class(es): Prokinetic agents and Prostaglandins. Its therapeutic use is listed as gastrointestinal agents and laxatives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Lubiprostone hemiketal and Lubiprostona. Its PubChem CID is 157920.
Lubiprostone
| CAS No | 333963-40-9 |
|---|---|
| Molecular Formula | C20H32F2O5 |
| Molecular Weight | 390.5 g/mol |
| Synonyms | 7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastrointestinal epithelial cells.
The listed CAS number is 333963-40-9.
The listed molecular formula is C20H32F2O5.
The listed molecular weight is 390.5 g/mol.
7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid.
The source lists Lubiprostone hemiketal and Lubiprostona.